Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aethlon Medical (AEMD) EBIT (2016 - 2023)

Historic EBIT for Aethlon Medical (AEMD) over the last 13 years, with Q1 2023 value amounting to -$2.5 million.

  • Aethlon Medical's EBIT rose 3454.55% to -$2.5 million in Q1 2023 from the same period last year, while for Mar 2023 it was -$11.9 million, marking a year-over-year decrease of 1418.46%. This contributed to the annual value of -$9.3 million for FY2025, which is 2607.67% up from last year.
  • Latest data reveals that Aethlon Medical reported EBIT of -$2.5 million as of Q1 2023, which was up 3454.55% from -$2.8 million recorded in Q4 2022.
  • Aethlon Medical's EBIT's 5-year high stood at -$876406.0 during Q4 2019, with a 5-year trough of -$3.8 million in Q1 2022.
  • For the 5-year period, Aethlon Medical's EBIT averaged around -$2.2 million, with its median value being -$2.1 million (2021).
  • Its EBIT has fluctuated over the past 5 years, first surged by 5537.36% in 2019, then crashed by 17891.07% in 2020.
  • Aethlon Medical's EBIT (Quarter) stood at -$876406.0 in 2019, then crashed by 178.91% to -$2.4 million in 2020, then dropped by 3.42% to -$2.5 million in 2021, then dropped by 12.73% to -$2.8 million in 2022, then grew by 13.05% to -$2.5 million in 2023.
  • Its last three reported values are -$2.5 million in Q1 2023, -$2.8 million for Q4 2022, and -$3.7 million during Q3 2022.